LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Your last searches

  1. AU="Barbieri, John S"
  2. AU="Bullerdiek, Jörn"

Search results

Result 1 - 10 of total 166

Search options

  1. Article ; Online: Potential Role of Calcitonin Gene-Related Peptide Inhibitors in the Treatment of Rosacea Flushing and Erythema.

    Barbieri, John S

    JAMA dermatology

    2024  

    Language English
    Publishing date 2024-04-17
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2701761-8
    ISSN 2168-6084 ; 2168-6068
    ISSN (online) 2168-6084
    ISSN 2168-6068
    DOI 10.1001/jamadermatol.2024.0397
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Isotretinoin for Treatment of Acne.

    Barbieri, John S

    JAMA dermatology

    2023  Volume 159, Issue 12, Page(s) 1403

    MeSH term(s) Humans ; Isotretinoin/adverse effects ; Acne Vulgaris/drug therapy ; Dermatologic Agents/adverse effects ; Treatment Outcome
    Chemical Substances Isotretinoin (EH28UP18IF) ; Dermatologic Agents
    Language English
    Publishing date 2023-10-11
    Publishing country United States
    Document type Patient Education Handout
    ZDB-ID 2701761-8
    ISSN 2168-6084 ; 2168-6068
    ISSN (online) 2168-6084
    ISSN 2168-6068
    DOI 10.1001/jamadermatol.2023.2065
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Strengths and Limitations of Study Designs Using Administrative Data to Assess Incidence and Prevalence of Disease.

    Barbieri, John S

    JAMA dermatology

    2023  Volume 159, Issue 9, Page(s) 991

    MeSH term(s) Humans ; Incidence ; Prevalence ; Research Design ; Databases, Factual
    Language English
    Publishing date 2023-07-13
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2701761-8
    ISSN 2168-6084 ; 2168-6068
    ISSN (online) 2168-6084
    ISSN 2168-6068
    DOI 10.1001/jamadermatol.2023.2161
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Temporal Trends in the Use of Systemic Medications for Acne From 2017 to 2020.

    Barbieri, John S

    JAMA dermatology

    2023  Volume 159, Issue 10, Page(s) 1135–1136

    MeSH term(s) Humans ; United States ; Acne Vulgaris/drug therapy ; Practice Patterns, Physicians' ; Retrospective Studies
    Language English
    Publishing date 2023-08-15
    Publishing country United States
    Document type Letter ; Research Support, N.I.H., Extramural
    ZDB-ID 2701761-8
    ISSN 2168-6084 ; 2168-6068
    ISSN (online) 2168-6084
    ISSN 2168-6068
    DOI 10.1001/jamadermatol.2023.2363
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Isotretinoin use for acne is not associated with an increased risk of migraine, fibromyalgia, multiple sclerosis, or neuropathy: A matched, retrospective cohort study.

    Barbieri, John S

    Journal of the American Academy of Dermatology

    2023  Volume 88, Issue 6, Page(s) 1390–1392

    MeSH term(s) Humans ; Isotretinoin/adverse effects ; Multiple Sclerosis/epidemiology ; Multiple Sclerosis/drug therapy ; Retrospective Studies ; Fibromyalgia/chemically induced ; Fibromyalgia/epidemiology ; Fibromyalgia/drug therapy ; Acne Vulgaris/drug therapy ; Acne Vulgaris/epidemiology ; Acne Vulgaris/chemically induced ; Anti-Bacterial Agents/therapeutic use ; Peripheral Nervous System Diseases/chemically induced ; Migraine Disorders/drug therapy ; Migraine Disorders/epidemiology ; Dermatologic Agents/adverse effects
    Chemical Substances Isotretinoin (EH28UP18IF) ; Anti-Bacterial Agents ; Dermatologic Agents
    Language English
    Publishing date 2023-02-13
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 603641-7
    ISSN 1097-6787 ; 0190-9622
    ISSN (online) 1097-6787
    ISSN 0190-9622
    DOI 10.1016/j.jaad.2023.02.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Effectiveness of spironolactone for women with acne vulgaris (SAFA) trial: a critically appraised topic.

    Shields, Ali / Barbieri, John S

    The British journal of dermatology

    2023  Volume 189, Issue 5, Page(s) 509–510

    MeSH term(s) Humans ; Female ; Spironolactone/therapeutic use ; Acne Vulgaris/drug therapy ; Drug Therapy, Combination
    Chemical Substances Spironolactone (27O7W4T232)
    Language English
    Publishing date 2023-07-27
    Publishing country England
    Document type Journal Article
    ZDB-ID 80076-4
    ISSN 1365-2133 ; 0007-0963
    ISSN (online) 1365-2133
    ISSN 0007-0963
    DOI 10.1093/bjd/ljad270
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: From Breakouts to Bargains: Strategies for Patient-Centered, Cost-effective Acne Care.

    Shields, Ali / Barbieri, John S

    Cutis

    2023  Volume 112, Issue 2, Page(s) E24–E29

    Abstract: A range of treatment options are available for both mild to moderate and moderate to severe acne, and these options vary widely in their clinical uses, effectiveness, and costs. With the continued rise of dermatologic drug prices and increased cost- ... ...

    Abstract A range of treatment options are available for both mild to moderate and moderate to severe acne, and these options vary widely in their clinical uses, effectiveness, and costs. With the continued rise of dermatologic drug prices and increased cost-sharing due to high-deductible health plans, the importance of cost-effective treatment continues to grow. Failure to consider cost-effective, patient-centered care may lead to increased financial toxicity, reduced adherence, and ultimately worse outcomes and patient satisfaction. Combination topical products offer improved efficacy and convenience, which are associated with better adherence and outcomes. Generic fixed-dose adapalene-benzoyl peroxide (BPO) and fixed-dose clindamycin-BPO can be highly cost-effective options for patients with mild to moderate acne. Hormonal agents such as combined oral contraceptives (COCs) and spironolactone are inexpensive and likely reflect a highly cost-effective option that could reduce reliance on oral antibiotics in patients with moderate to severe acne. Doxycycline and isotretinoin also are cost-effective options for more severe acne. Frequent laboratory monitoring for spironolactone and isotretinoin continues to be prevalent despite little evidence to support its clinical utility, and it is associated with a major cost burden to the patient and health care system. The reduction of laboratory monitoring is an opportunity to provide higher-value care.
    MeSH term(s) Humans ; Dermatologic Agents/therapeutic use ; Benzoyl Peroxide/therapeutic use ; Isotretinoin ; Adapalene/therapeutic use ; Cost-Benefit Analysis ; Spironolactone/therapeutic use ; Drug Combinations ; Acne Vulgaris/drug therapy ; Treatment Outcome ; Gels/therapeutic use
    Chemical Substances Dermatologic Agents ; Benzoyl Peroxide (W9WZN9A0GM) ; Isotretinoin (EH28UP18IF) ; Adapalene (1L4806J2QF) ; Spironolactone (27O7W4T232) ; Drug Combinations ; Gels
    Language English
    Publishing date 2023-10-10
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 391840-3
    ISSN 2326-6929 ; 0011-4162 ; 0151-9522
    ISSN (online) 2326-6929
    ISSN 0011-4162 ; 0151-9522
    DOI 10.12788/cutis.0844
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Emerging Medical Therapies in Rosacea: A Narrative Review.

    Choe, James / Barbieri, John S

    Dermatology and therapy

    2023  Volume 13, Issue 12, Page(s) 2933–2949

    Abstract: Rosacea is a chronic inflammatory disease with a multifactorial pathogenesis. The wide spectrum of clinical phenotypes, including erythema, telangiectasia, inflammatory papules and pustules, and phyma, demand an individualized approach to treatment. This ...

    Abstract Rosacea is a chronic inflammatory disease with a multifactorial pathogenesis. The wide spectrum of clinical phenotypes, including erythema, telangiectasia, inflammatory papules and pustules, and phyma, demand an individualized approach to treatment. This narrative review offers an updated reference for rosacea management by covering the latest developments in both topical and systemic treatments, including data from newly approved therapies, updates to current treatment modalities and ongoing clinical trials. Although use of benzoyl peroxide as a treatment for rosacea has typically been limited due to irritation, the improved tolerability due to microencapsulation of benzoyl peroxide 5% cream provides a new therapeutic option for patients with rosacea. Minocycline foam and topical ivermectin cream add to our armamentarium of treatment options, particularly for inflammatory papules and pustules. Sarecycline has a narrower spectrum of antibacterial activity, which might reduce the development of antibiotic resistance and disruption of the microbiome compared to other oral antibiotics. Brimonidine gel and oxymetazoline cream provide topical options for redness and flushing. There is emerging evidence about the role of hydroxychloroquine and intradermal botulinum toxin A, which may improve rosacea through their effects on mast cells. The clinical trials pipeline includes agents with a variety of mechanisms, including mast cell stabilization, antimicrobial, anti-inflammatory, and vasoconstrictive effects. However, the clinical pipeline for rosacea appears limited, and there remain important unmet needs for patients with more recalcitrant rosacea or phymatous disease. In addition, there is a need for comparative effectiveness studies to identify the highest value treatment approaches for patients with rosacea.
    Language English
    Publishing date 2023-10-12
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2680284-3
    ISSN 2190-9172 ; 2193-8210
    ISSN (online) 2190-9172
    ISSN 2193-8210
    DOI 10.1007/s13555-023-01048-1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Temporal trends and sociodemographic differences in face-to-face time spent with dermatologists, 2006-2016.

    Roster, Katie / Barbieri, John S

    Archives of dermatological research

    2023  Volume 315, Issue 9, Page(s) 2741–2744

    MeSH term(s) Humans ; Dermatologists ; Dermatology
    Language English
    Publishing date 2023-08-04
    Publishing country Germany
    Document type Letter
    ZDB-ID 130131-7
    ISSN 1432-069X ; 0340-3696
    ISSN (online) 1432-069X
    ISSN 0340-3696
    DOI 10.1007/s00403-023-02686-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Medicaid formularies for acne treatments are difficult to access and reflect inconsistent coverage policies.

    Ershadi, Sherry / Choe, James / Barbieri, John S

    Journal of the American Academy of Dermatology

    2024  Volume 90, Issue 5, Page(s) 1074–1076

    MeSH term(s) Humans ; Medicaid ; Isotretinoin ; Retinoids ; Policy ; Acne Vulgaris/drug therapy
    Chemical Substances Isotretinoin (EH28UP18IF) ; Retinoids
    Language English
    Publishing date 2024-01-28
    Publishing country United States
    Document type Journal Article
    ZDB-ID 603641-7
    ISSN 1097-6787 ; 0190-9622
    ISSN (online) 1097-6787
    ISSN 0190-9622
    DOI 10.1016/j.jaad.2024.01.033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top